Volastra Therapeutics
Latest round
- Series A
Last raised
- Mar 2023
Total raised
- $104M
Investors
- 9
About Volastra Therapeutics
Based in New York, US, and founded in 2019, Volastra Therapeutics, Inc. is a biotechnology company that provides treatment for metastatic cancers. The company was founded by Lewis Cantley, Olivier Elemento, and Samuel Bakhoum, and in March 2023, Volastra Therapeutics, Inc. Volastra Therapeutics, Inc. develops chromosomal instability (CIN)- targeted novel therapeutics that include KIF18A inhibitor, VLS-1488.
Who invested in Volastra Therapeutics
9 investors across 2 rounds
See all investors in Volastra Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Volastra Therapeutics
Who invested in Volastra Therapeutics?
Volastra Therapeutics has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Volastra Therapeutics raised?
Volastra Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Volastra Therapeutics last raise money?
Volastra Therapeutics's most recent round on record is a Series A, in Mar 2023.
What does Volastra Therapeutics do?
Based in New York, US, and founded in 2019, Volastra Therapeutics, Inc.
Where is Volastra Therapeutics headquartered?
Volastra Therapeutics is headquartered in New York, US.
Which VCs invest in companies like Volastra Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Volastra Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Volastra Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.